In Law360, IP Litigators Discuss Federal Circuit Ruling on Patent Venue Statute and Hatch-Waxman Act

In The News
November 18, 2020
Capital Insights.

Patent litigation over generic drugs, which has long been concentrated in Delaware and New Jersey, may spread out to more states across the country as a result of a recent Federal Circuit ruling, potentially making disputes more complicated,

In a Law360 article, IP litigation partner Matt Rizzolo (Washington, D.C.) provide insights on the patent venue statute and the Hatch-Waxman Act.

Matt expects the decision to be appealed further, and that there is a possibility that Congress could get involved to pass a new law.